Literature DB >> 20123710

Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.

Romain Paillot1, Carl Robinson, Karen Steward, Nicola Wright, Thibaud Jourdan, Nicola Butcher, Zoe Heather, Andrew S Waller.   

Abstract

Streptococcus equi is the causative agent of strangles, the most frequently diagnosed infectious disease of horses worldwide. The disease is characterized by abscessation and swelling of the lymph nodes of the head and neck, which can literally strangle the horse to death. S. equi produces four recently acquired phage-associated bacterial superantigens (sAgs; SeeH, SeeI, SeeL, and SeeM) that share homology with the mitogenic toxins of Streptococcus pyogenes. The aim of this study was to characterize the contribution of each of these S. equi sAgs to mitogenic activity in vitro and quantify the sAg-neutralizing capacity of sera from naturally infected horses in order to better understand their role in pathogenicity. Each of the sAgs was successfully cloned, and soluble proteins were produced in Escherichia coli. SeeI, SeeL, and SeeM induced a dose-dependent proliferative response in equine CD4 T lymphocytes and synthesis of gamma interferon (IFN-gamma). SeeH did not stimulate equine peripheral blood mononuclear cells (PBMC) but induced proliferation of asinine PBMC. Allelic replacement mutants of S. equi strain 4047 with sequential deletion of the superantigen genes were generated. Deletion of seeI, seeL, and seeM completely abrogated the mitogenic activity and synthesis of IFN-gamma, in equine PBMC, of the strain 4047 culture supernatant. Sera from naturally infected convalescent horses had only limited sAg-neutralizing activities. We propose that S. equi sAgs play an important role in S. equi pathogenicity by stimulating an overzealous and inappropriate Th1 response that may interfere with the development of an effective immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123710      PMCID: PMC2849420          DOI: 10.1128/IAI.01079-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Strangles, bastard strangles, vives and glanders: archaeological relics in a genomic age.

Authors:  J D Slater
Journal:  Equine Vet J       Date:  2003-03       Impact factor: 2.888

Review 2.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

3.  Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.

Authors:  Gila Arad; Dalia Hillman; Revital Levy; Raymond Kaempfer
Journal:  Immunol Lett       Date:  2004-02-15       Impact factor: 3.685

4.  Superantigens interact with MHC class II molecules outside of the antigen groove.

Authors:  P Dellabona; J Peccoud; J Kappler; P Marrack; C Benoist; D Mathis
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

Review 5.  Strangles.

Authors:  J F Timoney
Journal:  Vet Clin North Am Equine Pract       Date:  1993-08       Impact factor: 1.792

6.  An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections.

Authors:  Malak Kotb; Anna Norrby-Teglund; Allison McGeer; Hesham El-Sherbini; M Tevik Dorak; Ayesha Khurshid; Karen Green; Jeanie Peeples; Judy Wade; Glenys Thomson; Benjamin Schwartz; Donald E Low
Journal:  Nat Med       Date:  2002-11-18       Impact factor: 53.440

7.  Two novel superantigens found in both group A and group C Streptococcus.

Authors:  Thomas Proft; Phillip D Webb; Vanessa Handley; John D Fraser
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA.

Authors:  D Simon; J J Ferretti
Journal:  FEMS Microbiol Lett       Date:  1991-08-01       Impact factor: 2.742

9.  HLA class II polymorphisms determine responses to bacterial superantigens.

Authors:  Martin Llewelyn; Shiranee Sriskandan; Mark Peakman; David R Ambrozak; Daniel C Douek; William W Kwok; Jonathan Cohen; Daniel M Altmann
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

Review 10.  The pathogenic equine streptococci.

Authors:  John F Timoney
Journal:  Vet Res       Date:  2004 Jul-Aug       Impact factor: 3.683

View more
  10 in total

1.  Characterization of pneumonia due to Streptococcus equi subsp. zooepidemicus in dogs.

Authors:  Simon L Priestnall; Kerstin Erles; Harriet W Brooks; Jacqueline M Cardwell; Andrew S Waller; Romain Paillot; Carl Robinson; Alistair C Darby; Matthew T G Holden; Sandra Schöniger
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

2.  Identification of three novel superantigen-encoding genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and szeP.

Authors:  Romain Paillot; Alistair C Darby; Carl Robinson; Nicola L Wright; Karen F Steward; Emma Anderson; Katy Webb; Matthew T G Holden; Androulla Efstratiou; Karen Broughton; Keith A Jolley; Simon L Priestnall; Maria C Marotti Campi; Margaret A Hughes; Alan Radford; Kerstin Erles; Andrew S Waller
Journal:  Infect Immun       Date:  2010-08-16       Impact factor: 3.441

3.  Exacerbated type II interferon response drives hypervirulence and toxic shock by an emergent epidemic strain of Streptococcus suis.

Authors:  Claude Lachance; Marcelo Gottschalk; Pehuén P Gerber; Paul Lemire; Jianguo Xu; Mariela Segura
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

4.  Streptococcal sagA activates a proinflammatory response in mast cells by a sublytic mechanism.

Authors:  Christopher von Beek; Ida Waern; Jens Eriksson; Fabio Rabelo Melo; Carl Robinson; Andrew S Waller; Mikael E Sellin; Bengt Guss; Gunnar Pejler
Journal:  Cell Microbiol       Date:  2019-07-07       Impact factor: 3.715

5.  SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles.

Authors:  C Coral Dominguez-Medina; Nicola L Rash; Sylvain Robillard; Carl Robinson; Androulla Efstratiou; Karen Broughton; Julian Parkhill; Matthew T G Holden; Maria R Lopez-Alvarez; Romain Paillot; Andrew S Waller
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

6.  Differences in the Accessory Genomes and Methylomes of Strains of Streptococcus equi subsp. equi and of Streptococcus equi subsp. zooepidemicus Obtained from the Respiratory Tract of Horses from Texas.

Authors:  Ellen Ruth A Morris; Jing Wu; Angela I Bordin; Sara D Lawhon; Noah D Cohen
Journal:  Microbiol Spectr       Date:  2022-01-12

7.  Detection of Streptococcus equi subspecies equi using a triplex qPCR assay.

Authors:  Katy Webb; Colin Barker; Tihana Harrison; Zoe Heather; Karen F Steward; Carl Robinson; J Richard Newton; Andrew S Waller
Journal:  Vet J       Date:  2012-08-10       Impact factor: 2.688

8.  Transmission of Streptococcus equi subspecies zooepidemicus infection from horses to humans.

Authors:  Sinikka Pelkonen; Susanne B Lindahl; Päivi Suomala; Jari Karhukorpi; Sakari Vuorinen; Irma Koivula; Tia Väisänen; Jaana Pentikäinen; Tiina Autio; Tamara Tuuminen
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

9.  Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.

Authors:  Yasmin Z Paterson; Nicola Rash; Elaine R Garvican; Romain Paillot; Deborah J Guest
Journal:  Stem Cell Res Ther       Date:  2014-07-30       Impact factor: 6.832

10.  Strangles in Arabian horses in Egypt: Clinical, epidemiological, hematological, and biochemical aspects.

Authors:  Ahmed N F Neamat-Allah; Hend M El Damaty
Journal:  Vet World       Date:  2016-08-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.